COVID-19 vaccine to be available at end of 2020: AstraZeneca
AstraZeneca, the British pharmaceutical company, said on Thursday it was still possible for its coronavirus vaccine to be available at the end of this year or the beginning of 2021. "I still think we are on track for having a set of data that we would submit before the end of the year. We could still have a vaccine by the end of this year, early next year," AstraZeneca CEO Pascal Soriot said.
- World
- Agencies and A News
- Published Date: 05:41 | 10 September 2020
- Modified Date: 05:41 | 10 September 2020
AstraZeneca's chief executive Pascal Soriot said on Thursday that it should know before the end of the year whether its experimental vaccine would protect people from COVID-19, if the British drugmaker is allowed to resume trials which were paused this week.
It suspended the late-stage trials after an illness in a study subject in Britain. The patient was reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.
Soriot said during a call on the vaccine, which the World Health Organization (WHO) has flagged as the most promising in combatting coronavirus, that it was very common for a trial to be suspended, the difference being that the world was watching.
The CEO said AstraZeneca did not know the diagnosis for the volunteer in the trial, adding that it was not clear if they had transverse myelitis and more tests were needed.
Soriot said the diagnosis would be submitted to an independent safety committee and this would usually then tell the company whether trials can be resumed.
- Russian hackers target U.S. campaigns, parties: Microsoft
- Pompeo to attend start of intra-Afghan peace talks in Doha
- U.S. trying to get other Gulf nations to join in normalizing ties with Israel
- Dozens of schools in Spain report virus cases after reopening
- Taliban says ready to start Intra-Afgan talks in Doha